Exelife Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.60 M
- Revenue Growth 27.69%
- Profit Growth 187.38%
- Ebitda 1469.73%
- Net Worth 3.06%
- Total Assets 16.79%
About Exelife Biotech
Exelife Biotech Private Limited (EBPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 August 2014 and has a history of Ten years and six months. Its registered office is in Varanasi, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.60 M.
Anil Verma and Priti Verma serve as directors at the Company.
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74120UP2014PTC065713
- Company No.
065713
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Exelife Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Verma  | Director | 27-Aug-2014 | Current |
| Priti Verma | Director | 27-Aug-2014 | Current |
Financial Performance of Exelife Biotech.
Exelife Biotech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 27.69% increase. The company also saw a substantial improvement in profitability, with a 187.38% increase in profit. The company's net worth moved up by a moderate rise of 3.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Exelife Biotech?
In 2018, Exelife Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.60 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jan 2022 | Others | ₹0.60 M | Open |
How Many Employees Work at Exelife Biotech?
Unlock and access historical data on people associated with Exelife Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Exelife Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exelife Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.